Vitamin D is a potent antioxidant that is proving to be a significant factor in restoring prostate health in men with BPH (benign prostatic hyperplasia). A study published in Urology International reported that the vitamin D genotype has an important role in determining the risk of BPH. (Hamasaki 2002) Research also indicates that a low level of vitamin D is associated with a greater risk of having an enlarged prostate. (Galic 2008) Investigators in Italy found that a synthetic derivative of vitamin D3 can stop the growth of the prostate in men who have BPH, information that can help scientists develop a more effective way to treat the condition. (Penna 2009) A more recent report noted that vitamin D receptor agonists, which have anti-inflammatory activity, may have an important role in the treatment of BPH. (Fibbi 2010) Individuals should have their vitamin D levels checked with a blood test to determine if they are deficient and a knowledgeable healthcare provider can choose the best supplement dose. The Vitamin D Council recommends blood levels of vitamin D to be between 50 and 80 ng/mL. Read more on vitamin D and BPH
See also
Top Supplements for Prostatitis
Top Supplements for Prostate Cancer
Top Supplements for Erectile Dysfunction
Top Supplements for ED and Sexual Health
Top Supplements for Men’s Health
References
Fibbi B etg al. Chronic inflammation in the pathogenesis of benign prostatic hyperplasia. Int J Andol 2010 Jun 1; 33(3): 475-88
Galic J, Simunovic D. Prostate disease prevalence with epidemiological and hormonal analysis in randomly selected male population in Croatia. Coll Anthropol 2008; 32(4): 1195-102
Penna G et al. The vitamin D receptor agonist elocalcitol inhibits IL-8-dependent benign prostatic hyhperplasia stromal cell proliferation and inflammatory response by targeting the RhoA/Rho kinase and NF-kappaB pathways. Prostate 2009 Apr 1; 69(5): 480-93
